The genetics of addictiona translational perspective

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Agrawal, A ^a   Verweij, K J H ^b,c   Gillespie, N A ^d   Heath, A C ^a   Lessov Schlaggar, C N ^a   Martin, N G ^b   Nelson, E C ^a   Slutske, W S ^e   Whitfield, J B ^b   Lynskey, M T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

Author keywords

Addiction; drug; genetics; substance

Indexed keywords

ACAMPROSATE; ALCOHOL; AMFEBUTAMONE; BIOLOGICAL MARKER; CANNABIS; COCAINE; NALTREXONE; NICOTINE; ONDANSETRON; OPIATE; SERTRALINE; TRANSFERRIN; VARENICLINE;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ALCOHOLISM; BEHAVIOR; BIOINFORMATICS; BIOSTATISTICS; CANNABIS ADDICTION; CHROMOSOME 15; COCAINE DEPENDENCE; COPY NUMBER VARIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG METABOLISM; DSM-5; DSM-IV; ENDOPHENOTYPE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENETICS; GENOME; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HETEROZYGOTE; HUMAN; METHODOLOGY; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; OPIATE ADDICTION; OUTCOME ASSESSMENT; PATHOLOGICAL GAMBLING; PHARMACOGENOMICS; PHENOTYPE; PUBLIC HEALTH; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TRANSLATIONAL RESEARCH; CLASSIFICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; PHARMACOGENETICS;

BIOLOGICAL MARKERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENDOPHENOTYPES; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; PHARMACOGENETICS; SUBSTANCE-RELATED DISORDERS;

EID: 84864256405     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.54     Document Type: Review

References (216)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, Revised edn. American Psychiatric Association: Washington, DC, 1994.
2. Centers for Disease Control (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs-United States. MMWR2002; 51: 300-303.
3. Centers for Disease Control (CDC). Alcohol-Attributable Deaths and Years of Potential Life Lost\-United States, 2001. MMWR2004; 53: 870.
4. O'Brien C. Addiction and dependence in DSM-V. Addiction 2011; 106: 866-867.
5. Petry NM. Gambling and substance use disorders: current status and future directions. Am JAddict2007; 16:1-9. (Pubitemid 46341012)
6. Frascella J, Potenza MN, Brown LL, Childress AR. Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint? Ann N Y Acad Sci 2010; 1187: 294-315.
7. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 1999; 29: 299-308. (Pubitemid 29129315)
8. Lessov CN, Martin NG,Statham DJ,Todorov AA,Slutske WS, Bucholz KKetal.Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med 2004; 34: 865-879. (Pubitemid 39089525)
9. Edwards AC, Maes HH, Pedersen NL, Kendler KS. A population-based twin study of the genetic and environmental relationship of major depression, regular tobacco use and nicotine dependence. Psychol Med2011; 41: 395-405.
10. Lyons M, Hitsman B, Xian H, Panizzon MS, Jerskey BA, Santangelo S etal. Atwin study of smoking, nicotine dependence, and major depression in men. Nicotine Tob Res 2008; 10: 97-108.
11. Prescott CA, Kendler KS. Genetic and Environmental Influences on Alcohol and Tobacco Dependence among Women. NIAAA Res Monogr1995; 30: 59-87.
12. Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ.Apopulation- basedtwinstudy of alcoholism in women. JAMA 1992; 268:1877-1882.
13. Heath AC, Martin NG. Genetic influences on alcohol consumption patterns and problem drinking: results from the Australian NH&MRC twin panel follow-up survey. Ann N YAcad Sci1994; 708: 72-85. (Pubitemid 24121464)
14. Heath AC, Whitfield JB, Madden PA, Bucholz KK, Dinwiddie SH, Slutske WS et al. Towards a molecular epidemiology of alcohol dependence: analysing the interplay of genetic and environmental riskfactors. Br JPsychiatry Suppl2001; 40: s33-s40. (Pubitemid 32269768)
15. Verweij KJ, Zietsch BP, Lynskey MT, Medland SE, Neale MC, Martin NG etal. Genetic and environmental influences on cannabis use initiation and problematic use: a meta-analysis of twin studies. Addiction 2010; 105: 417-430.
16. Kendler KS, Karkowski LM, Neale MC, Prescott CA. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry2000; 57: 261-269. (Pubitemid 30140435)
17. Tsuang MT, Bar JL, Harley RM, Lyons MJ. The Harvard Twin Study of Substance Abuse: what we have learned. Harv Rev Psychiatry 2001; 9: 267-279. (Pubitemid 33010369)
18. van den Bree MB, Johnson EO, Neale MC, Pickens RW. Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend 1998; 52: 231-241. (Pubitemid 28529581)
19. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J etal. Co-occurrence of abuse of different drugs in men: the role of drug- specific and shared vulnerabilities. Arch Gen Psychiatry 1998; 55: 967-972. (Pubitemid 28506837)
20. Slutske WS, Zhu G, Meier MH, Martin NG. Genetic and environmental influences on disordered gambling in men and women. Arch Gen Psychiatry2010; 67: 624-630.
21. Slutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry 2000; 57: 666-673. (Pubitemid 30445858)
22. Heath AC, Martin NG, Lynskey MT, Todorov AA, Madden PA. Estimating two-stage models for genetic influences on alcohol, tobacco or drug use initiation and dependence vulnerability in twin and family data. Twin Res 2002; 5:113-124. (Pubitemid 34407939)
23. Neale MC, Harvey E, Maes HH, Sullivan PF, Kendler KS. Extensions to the modeling of initiation and progression: applications to substance use and abuse. Behav Genet2006; 36: 507-524. (Pubitemid 43967647)
24. Agrawal A, Neale M, Jacobson K, Prescott CA, Kendler KS. Illicit drug use and abuse/ dependence: modeling of two-stage variables using the CCC approach. Addict Behav 2005;30:1043-1048. (Pubitemid 40693740)
25. Heath AC, Lynskey MT, Waldron M. Substance use. In: Rutter M, Taylor E (eds). Handbook of Child and Adolescent Psychiatry. Blackwell: London, 2007.
26. Dick DM, Pagan JL, Viken R, Purcell S, Kaprio J, Pulkkinen L et al. Changing environmental influences on substance use across development. Twin Res Hum Genet 2007; 10: 315-326. (Pubitemid 46658528)
27. Kendler KS, Schmitt E, Aggen SH, Prescott CA. Geneticand environmental influenceson alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry 2008; 65: 674-682. (Pubitemid 351787238)
28. Derringer J, Krueger RF, Mc Gue M, Iacono WG. Genetic and environmental contributions to the diversity of substances used in adolescent twins: a longitudinal study of age and sex effects. Addiction 2008; 103:1744-1751.
29. Derringer J, Krueger RF, Iacono WG,Mc Gue M. Modelingtheimpactofageandsexona dimension of poly-substance use in adolescence: a longitudinal study from 11- to 17-years-old. Drug Alcohol Depend 2010; 110:193-199.
30. Rhee SH, Hewitt JK, Young SE, Corley RP, Crowley TJ, Stallings MC. Genetic and environmental influences on substance initiation, use, and problem use in adolescents. Arch Gen Psychiatry2003; 60:1256-1264. (Pubitemid 37494079)
31. Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003; 160: 687-695. (Pubitemid 41079601)
32. Kendler KS, Myers J, Prescott CA. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence. Arch Gen Psychiatry2007; 64:1313-1320. (Pubitemid 350074829)
33. Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health 2007; 30: 5-13.
34. Dick DM, Bierut LJ. The genetics of alcohol dependence. Curr Psychiatry Rep 2006; 8: 151-157.
35. Mc Hugh RK, Hofmann SG, Asnaani A, Sawyer AT, Otto MW. The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. Drug Alcohol Depend 2010; 108:1-6.
36. Edenberg HJ, Dick DM, Xuei X, Tian H, Almasy L, Bauer LO et al. Variations in GABRA2, encoding the alpha 2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet 2004; 74: 705-714. (Pubitemid 38420099)
37. Lappalainen J, Krupitsky E, Remizov M, Pchelina S, Taraskina A, Zvartau E et al. Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. Alcohol Clin Exp Res 2005; 29: 493-498. (Pubitemid 40547851)
38. Fehr C, Sander T, Tadic A, Lenzen KP, Anghelescu I, Klawe C etal. Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis. Psychiatr Genet 2006;16:9-17. (Pubitemid 44481214)
39. Lind P, Mac Gregor S, Agrawal A, Heath AC, Martin NG, Whitfield JB. The role of GABRA2 in alcohol dependence, smoking and illicit drug use in an australian population sample. Alcohol Clin Exp Res 2008; 32:1721-1731.
40. Covault J, Gelernter J, Hesselbrock V, Nellissery M, Kranzler HR. Allelic and haplotypic association of GABRA2 with alcohol dependence. Am J Med Genet B Neuropsychiatr Genet2004; 129: 104-109. (Pubitemid 38989078)
41. Drgon T, D'Addario C, Uhl GR. Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictions. Am J Med Genet B Neuropsychiatr Genet 2006;141: 854-860. (Pubitemid 44905438)
42. Han S, Yang BZ, Kranzler HR, Oslin D, Anton R, Gelernter J. Association of CHRNA4 polymorphisms with smoking behavior in two populations. Am J Med Genet B Neuropsychiatr Genet2011; 156B: 421-429.
43. Keskitalo-Vuokko K, Pitkaniemi J, Broms U, Heliovaara M, Aromaa A, Perola M et al. Associations of nicotine intake measures with CHRN genes in finnish smokers. Nicotine Tob Res 2011;13: 686-690.
44. Xie P, Kranzler HR, Krauthammer M, Cosgrove KP, Oslin D, Anton RF et al. Rare nonsynonymous variants in Alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry 2011; 70: 528-536.
45. Munafo MR, Timpson NJ, David SP, Ebrahim S, Lawlor DA. Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res 2009;11: 64-76.
46. Agrawal A, Lynskey MT. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction 2009; 104: 518-532.
47. Agrawal A, Edenberg HJ, Foroud T, Bierut LJ, Dunne G, Hinrichs AL etal. Association of GABRA2 with drug dependence in the collaborative study of the genetics of alcoholism sample. Behav Genet2006; 36: 640-650. (Pubitemid 44188079)
48. Corley RP, Zeiger JS, Crowley T, Ehringer MA, Hewitt JK, Hopfer CJ etal. Association of candidate genes with antisocial drug dependence in adolescents. Drug Alcohol Depend 2008; 96: 90-98.
49. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ etal. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet2006; 15: 3498-3507. (Pubitemid 44884117)
50. Luo X, Kranzler H, Lappalainen J, Rosenheck R, Charney D, Zuo L etal. CALCYON gene variation, schizophrenia, and cocaine dependence. Am J Med Genet B Neuropsychiatr Genet2004; 125B: 25-30. (Pubitemid 38141398)
51. Kalayasiri R, Sughondhabirom A, Gueorguieva R, Coric V, Lynch WJ, Lappalainen J et al. Dopamine beta-hydroxylase gene (Dbeta H) -1021C→T influences self-reported paranoia during cocaine self-administration. Biol Psychiatry 2007; 61:1310-1313. (Pubitemid 46726260)
52. Ittiwut R, Listman JB, Ittiwut C,Cubells JF,Weiss RD, Brady Ket al. Association between polymorphisms in catechol-O-methyltransferase (COMT) and cocaine-induced paranoia in European-American and African-American populations. Am J Med Genet B Neuropsychiatr Genet2011; 156: 651-660.
53. Zhang H, Kranzler HR, Weiss RD, Luo X, Brady KT, Anton RF et al. Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry2009; 66:128-136.
54. Zuo L, Kranzler HR, Luo X, Yang BZ, Weiss R, Brady K et al. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Neuropsychopharmacology 2009; 34:1504-1513.
55. Malison RT, Kranzler HR, Yang BZ, Gelernter J. Human clock, PER1 and PER2 polymorphisms: lack of association with cocaine dependence susceptibility and cocaine-induced paranoia. Psychiatr Genet 2006; 16: 245-249. (Pubitemid 44760304)
56. Dahl JP, Cubells JF, Ray R, Weller AE, Lohoff FW, Ferraro TN et al. Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence. Addict Biol 2006; 11: 76-83. (Pubitemid 46696739)
57. Farrer LA, Kranzler HR,Yu Y, Weiss RD, Brady KT, Anton R et al. Association of variants in MANEA with cocaine-related behaviors. Arch Gen Psychiatry2009; 66: 267-274.
58. Grucza RA, Wang JC, Stitzel JA, Hinrichs AL, Saccone SF, Saccone NL et al.A riskallele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. Biol Psychiatry2008; 64: 922-929.
59. Sherva R, Kranzler HR, Yu Y, Logue MW, Poling J, Arias AJ et al. Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes. Neuropsychopharmacology 2010; 35:1921-1931.
60. Uhl GR, Sora I, Wang Z. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci USA 1999; 96: 7752-7755. (Pubitemid 29328353)
61. Bond C, La Forge KS, Tian M, Melia D, Zhang S, Borg L et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A 1998; 95: 9608-9613. (Pubitemid 28506279)
62. Kroslak T, La Forge KS, Gianotti RJ, Ho A, Nielsen DA, Kreek MJ. The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem 2007; 103: 77-87. (Pubitemid 47404205)
63. La Forge KS, Yuferov V, Kreek MJ. Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur JPharmacol2000; 410: 249-268. (Pubitemid 32008148)
64. Pan L, Xu J, Yu R, Xu MM, Pan YX, Pasternak GW. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm. Neuroscience 2005; 133: 209-220. (Pubitemid 40694171)
65. Glatt SJ, Bousman C, Wang RS, Murthy KK, Rana BK, Lasky-Su JA et al. Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend2007; 90:159-165. (Pubitemid 47299168)
66. Ray R, Doyle GA, Crowley JJ, Buono RJ, Oslin DW, Patkar AA et al. A functional prodynorphin promoter polymorphism and opioid dependence. Psychiatr Genet2005; 15: 295-298. (Pubitemid 44491469)
67. Comings DE, Blake H, Dietz G, Gade-Andavolu R, Legro RS, Saucier G et al. The proenkephalin gene (PENK) and opioid dependence. Neuroreport 1999; 10:1133-1135. (Pubitemid 29318002)
68. Gerra G, Leonardi C, Cortese E, D'Amore A, Lucchini A, Strepparola G et al. Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 771-775. (Pubitemid 47417206)
69. Zhang H, Kranzler HR, Yang BZ, Luo X, Gelernter J. The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 2008; 13: 531-543. (Pubitemid 351556028)
70. Franke P, Nothen MM, Wang T, Neidt H, Knapp M, Lichtermann D et al. Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am J Med Genet 1999; 88: 462-464. (Pubitemid 29485068)
71. Mayer P, Rochlitz H, Rauch E, Rommelspacher H, Hasse HE, Schmidt S et al. Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport 1997; 8: 2547-2550. (Pubitemid 27308458)
72. Lobo DS, Kennedy JL. Genetic aspects of pathological gambling: a complexdisorder with shared genetic vulnerabilities. Addiction 2009; 104:1454-1465.
73. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 1997; 2: 44-56. (Pubitemid 27163110)
74. da Silva Lobo DS, Vallada HP, Knight J, Martins SS, Tavares H, Gentil V et al. Dopamine genes and pathological gambling in discordant sib-pairs. J Gambl Stud2007; 23: 421-433.
75. Lobo DS, Souza RP, Tong RP, Casey DM, Hodgins DC, Smith GJ et al. Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects. Biol Psychol2010; 85: 33-37.
76. Thomasson HR, Crabb DW, Edenberg HJ, Li TK. Alcohol and aldehyde dehydrogenase polymorphisms and alcoholism. Behav Genet 1993; 23:131-136. (Pubitemid 23149929)
77. Higuchi S, Matsushita S, Imazeki H, Kinoshita T, Takagi S, Kono H. Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet1994; 343: 741-742. (Pubitemid 24087883)
78. Lee HC, Lee HS, Jung SH, Yi SY, Jung HK, Yoon JH et al. Association between polymorphisms of ethanol-metabolizing enzymes and susceptibility to alcoholic cirrhosis in a Korean male population. J Korean Med Sci 2001; 16: 745-750. (Pubitemid 33741062)
79. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology 2010; 35: 217-238.
80. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 2007; 64: 1575-1579. (Pubitemid 350106758)
81. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF et al. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet2007; 16: 24-35. (Pubitemid 46152542)
82. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P et al. Genome-wide association study of alcohol dependence. Arch Gen Psychiatry2009; 66: 773-784.
83. Frank J, Cichon S, Treutlein J, Ridinger M, Mattheisen M, Hoffmann P et al. Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol 2012; 17:171-180.
84. Edenberg HJ, Koller DL, Xuei X, Wetherill L, Mc Clintick JN, Almasy L et al. Genome-wide association study of alcohol dependence implicates a region on chromosome 11. Alcohol Clin Exp Res 2010; 34: 840-852.
85. Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E et al. A genome-wide association study of alcohol dependence. Proc Natl Acad Sci U S A 2010; 107: 5082-5087.
86. Heath AC, Whitfield JB, Martin NG, Pergadia ML, Goate AM, Lind PA et al. A quantitative-trait genome-wide association study of alcoholism risk in the community: findings and implications. Biol Psychiatry 2011; 70: 513-518.
87. Agrawal A, Lynskey MT, Hinrichs A, Grucza R, Saccone SF, Krueger R et al. A genome-wide association study of DSM-IV cannabis dependence. Addict Biol 2011; 16: 514-518.
88. Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet2010; 42: 441-447.
89. Thorgeirsson TE, Gudbjartsson DF, Surakka I,Vink JM, Amin N, Geller F et al. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet2010; 42: 448-453.
90. Liu JZ,Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L et al. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet2010; 42: 436-440.
91. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association studytargeting348candidate geneswith3713 SNPs. Hum Mol Genet2007; 16: 36-49. (Pubitemid 46152543)
92. Schumann G, Coin LJ, Lourdusamy A, Charoen P, Berger KH, Stacey D et al. Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) inthe regulation of alcohol consumption. Proc Natl Acad Sci U S A 2011; 108: 7119-7124.
93. Maher B. Personal genomes: the case of the missing heritability. Nature 2008; 456: 18-21.
94. Maher B. The search for the genome 'Dark Matter' moves closer. Nature News 2008; 1235, doi:10.1038/news.2008.1235.
95. Yang J, Benyamin B, Mc Evoy BP, Gordon S, Henders AK, Nyholt DR et al. Common SNPsexplainalargeproportionofthe heritabilityfor human height. Nat Genet2010; 42: 565-569.
96. Johnson C, Drgon T, Liu QR, Zhang PW, Walther D, Li CY et al. Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples. BMC Med Genet2008; 9:113.
97. Drgon T, Johnson CA, Nino M, Drgonova J, Walther DM, Uhl GR. 'Replicated' genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs. Am J Med Genet B Neuropsychiatr Genet2011; 156: 125-138.
98. Johnson C, Drgon T, Walther D, Uhl GR. Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. PLo S One2011; 6: e19210.
99. Yang J, Manolio TA, Pasquale LR, Boerwinkle E, Caporaso N, Cunningham JM et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet2011; 43: 519-525.
100. Davies G, Tenesa A, Payton A, Yang J, Harris SE, Liewald D et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry 2011; 16: 996-1005.
101. Bierut LJ, Goate AM, Breslau N, Johnson EO, Bertelsen S, Fox L et al. ADH1B is associated with alcohol dependence and alcohol consumption in populations of European and African ancestry. Mol Psychiatry2012; 17: 445-450.
102. Agrawal A, Pergadia ML, Saccone SF, Lynskey MT, Wang JC, Martin NG et al. An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. Arch Gen Psychiatry2008; 65: 713-721.
103. Grant JD, Agrawal A, Bucholz KK, Madden PA, Pergadia ML, Nelson EC et al. Alcohol consumption indices of genetic risk for alcohol dependence. Biol Psychiatry 2009; 66: 795-800.
104. Agrawal A, Grant JD, Littlefield A, Waldron M, Pergadia ML, Lynskey MT et al. Developing a quantitative measure of alcohol consumption for genomic studies on prospective cohorts. J Stud Alcohol Drugs 2009; 70:157-168.
105. Kendler KS, Myers J, Dick D, Prescott CA.The relationshipbetweengeneticinfluenceson alcohol dependence and on patterns of alcohol consumption. Alcohol Clin Exp Res 2010; 34:1058-1065.
106. Dick DM, Meyers JL, Rose RJ, Kaprio J, Kendler KS. Measures of current alcohol consumption and problems: two independent twin studies suggest a complex genetic architecture.Alcohol Clin Exp Res2011; 35: 2152-2161.
107. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J. Validity of the Fagerstrom test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Br JAddict1989; 84: 791-799.
108. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86:1119-1127.
109. Moolchan ET, Aung AT, Henningfield JE. Treatment of adolescent tobacco smokers: issues and opportunitiesforexposure reduction approaches. Drug Alcohol Depend2003; 70: 223-232. (Pubitemid 36577334)
110. Schuckit MA, Gold EO. A simultaneous evaluation of multiple markers of ethanol/placebo challenges in sons of alcoholics and controls. Arch Gen Psychiatry1988; 45: 211-216. (Pubitemid 18081668)
111. Schuckit M. Vulnerability factors for alcoholism. In: Davis K (ed). Neuropsycho-pharmacology: The Fifth Generation of Progress. Lippincott Williams and Wilkins: Baltimore, 2002.
112. Schuckit MA, Smith TL, Kalmijn J. The search for genes contributing to the low level of response to alcohol: patterns of findings across studies. Alcohol Clin Exp Res 2004; 28: 1449-1458. (Pubitemid 39390465)
113. Vogel-Sprott M, Chipperfield B. Family history of problem drinking among young male social drinkers: behavioral effects of alcohol. J Stud Alcohol1987; 48: 430-436. (Pubitemid 17132176)
114. Ramchandani VA, Flury L, Morzorati SL, Kareken D, Blekher T, Foroud T et al. Recent drinking history: association with family history of alcoholism and the acute response to alcohol during a 60mg% clamp. JStud Alcohol2002; 63: 734-744. (Pubitemid 36042322)
115. Roh S, Matsushita S, Hara S, Maesato H, Matsui T, Suzuki G et al. Role of GABRA2 in moderating subjective responses to alcohol. Alcohol Clin Exp Res 2011; 35: 400-407.
116. Pierucci-Lagha A, Covault J, Feinn R, Nellissery M, Hernandez-Avila C, Oncken C et al. GABRA2 alleles moderate the subjective effects of alcohol, which are attenuated byfinasteride. Neuropsychopharmacology 2005; 30:1193-1203. (Pubitemid 40720979)
117. Hu X, Oroszi G, Chun J, Smith TL, Goldman D, Schuckit MA. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005; 29: 8-16. (Pubitemid 40129206)
118. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-645. (Pubitemid 41079594)
119. Kendler KS, Neale MC. Endophenotype: a conceptual analysis. Mol Psychiatry2010; 15: 789-797.
120. Cannon TD, Keller MC. Endophenotypes in the genetic analyses of mental disorders. Annu Rev Clin Psychol2006; 2: 267-290. (Pubitemid 43799806)
121. Field M, Cox WM. Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug Alcohol Depend2008; 97:1-20.
122. Rangaswamy M, Porjesz B. Uncovering genes for cognitive (dys)function and predisposition for alcoholism spectrum disorders: a review of human brain oscillations as effective endophenotypes. Brain Res2008; 1235:153-171.
123. Porjesz B, Rangaswamy M. Neurophysiological endophenotypes, CNS disinhibition, and risk for alcohol dependence and related disorders. Scientific World Journal 2007; 7: 131-141. (Pubitemid 350277589)
124. Begleiter H, Porjesz B. Genetics of human brain oscillations. Int JPsychophysiol2006; 60:162-171. (Pubitemid 43776731)
125. Porjesz B, Almasy L, Edenberg HJ, Wang K, Chorlian DB, Foroud T et al. Linkage disequilibrium between the beta frequency of the human EEG and a GABAA receptor gene locus. Proc Natl Acad Sci U SA 2002; 99: 3729-3733. (Pubitemid 34252174)
126. Kutalik Z, Benyamin B, Bergmann S, Mooser V, Waeber G, Montgomery GW et al. Genome-wide association study identifies two loci strongly affecting transferrin glycosylation. Hum Mol Genet2011; 20: 3710-3717.
127. Villafuerte S, Heitzeg MM, Foley S, Wendy Yau WY, Majczenko K, Zubieta JK et al. Impulsiveness and insula activation during reward anticipation are associated with genetic variants in GABRA2 in a family sample enriched for alcoholism. Mol Psychiatry 2012; 17: 511-519.
128. Nikolova YS, Ferrell RE, Manuck SB, Hariri AR. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology2011;36:1940-1947.
129. Hamilton CM,Strader LC, Pratt JG, Maiese D, Hendershot T, Kwok RKet al. The Phen X toolkit: getthe mostfrom your measures. Am J Epidemiol 2011; 174: 253-260.
130. Stankiewicz P, Lupski Jr. Structural variation in the human genome and its role in disease. Annu Rev Med 2010; 61: 437-455.
131. Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 2010; 467:1061-1073.
132. Renthal W, Nestler EJ. Epigenetic mechanisms in drug addiction. Trends Mol Med2008; 14:341-350.
133. Maze I, Nestler EJ. The epigenetic landscape of addiction. Ann N YAcad Sci2011; 1216: 99-113.
134. Wong CC, Mill J, Fernandes C. Drugs and addiction: an introduction to epigenetics. Addiction 2011; 106: 480-489.
135. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A et al. The NIH roadmap epigenomics mapping consortium. Nat Biotechnol 2010; 28: 1045-1048.
136. Myers RM, Stamatoyannopoulos J, Snyder M, Dunham I, Hardison RC, Bernstein BE et al. A user's guide to the encyclopedia of DNA elements (ENCODE). PLo S Biol2011; 9: e1001046.
137. Hurley JH, Ballard CJ, Edenberg HJ. Altering the relative abundance of GABA A receptor subunits changes GABA- and ethanol-responses in Xenopus oocytes. Alcohol Clin Exp Res2009; 33:1089-1096.
138. Liu J, Yang AR, Kelly T, Puche A, Esoga C, June Jr HL et al. Binge alcohol drinking is associated with GABAA alpha2-regulated Toll-like receptor 4 (TLR4) expression in the central amygdala. Proc Natl Acad Sci U S A 2011; 108: 4465-4470.
139. Purcell S, Neale B,Todd-Brown K,Thomas L, Ferreira MA, Bender D et al. PLINK:atool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
140. Liu JZ, Mc Rae AF, Nyholt DR, Medland SE, Wray NR, Brown KM et al. A versatile gene-based test for genome-wide association studies. Am J Hum Genet 2010; 87:139-145.
141. Raychaudhuri S, Plenge RM, Rossin EJ, Ng AC, Purcell SM, Sklar P et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLo S Genet2009; 5: e1000534.
142. Li MX, Gui HS, Kwan JS, Sham PC GATES: a rapid and powerful gene-based association test using extended Simes procedure. Am JHum Genet2011; 88: 283-293.
143. Ruano D, Abecasis GR, Glaser B, Lips ES, Cornelisse LN, de Jong AP et al. Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am JHum Genet2010; 86:113-125.
144. Reimers MA, Riley BP, Kalsi G, Kertes DA, Kendler KS. Pathway based analysis of genotypes in relation to alcohol dependence. Pharmacogenomics J 2011 (in press).
145. Harris MA, Clark J, Ireland A, Lomax J,Ashburner M, Foulger R et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004; 32(Database issue): D258-D261. (Pubitemid 38081651)
146. Scarr S, Mc Cartney J. How people make their own environment: a theory of genotype greater than environmental effects. Child Dev1983; 54: 424-435.
147. Heath AC, Nelson EC Effects of the interaction between genotype and environment. Research into the genetic epidemiology of alcohol dependence. Alcohol Res Health 2002; 26: 193-201.
148. Dick DM, Rose RJ, Viken RJ, Kaprio J, Koskenvuo M. Exploring gene-environment interactions: socioregional moderation of alcohol use. J Abnorm Psychol2001; 110: 625-632. (Pubitemid 33049425)
149. Dick DM, Bernard M, Aliev F, Viken R, Pulkkinen L, Kaprio J et al. The role of socioregional factors in moderating genetic influences on early adolescent behavior problems and alcohol use. Alcohol Clin Exp Res 2009; 33:1739-1748.
150. Dick DM, Viken R, Purcell S, Kaprio J, Pulkkinen L, Rose RJ. Parental monitoring moderates the importance of genetic and environmental influences on adolescent smoking. J Abnorm Psychol2007; 116: 213-218. (Pubitemid 46328612)
151. Button TM,Stallings MC, Rhee SH,Corley RP, Boardman JD, Hewitt JK. Perceivedpeer delinquency and the genetic predisposition for substance dependence vulnerability. Drug Alcohol Depend2009; 100:1-8.
152. Agrawal A, Balasubramanian S, Smith EK, Madden PA, Bucholz KK, Heath AC et al. Peer substance involvement modifies genetic influences on regular substance involvement in young women. Addiction 2010; 105:1844-1853.
153. Caspi A, Moffitt TE. Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006; 7: 583-590. (Pubitemid 43995433)
154. Rutter M, Moffitt TE, Caspi A. Gene-environment interplay and psychopathology: multiple varieties but real effects. J Child Psychol Psychiatry 2006; 47: 226-261. (Pubitemid 43356058)
155. Dick DM, Latendresse SJ, Lansford JE, Budde JP, Goate A, Dodge KA et al. Role of GABRA2 in trajectories of externalizing behavior across development and evidence of moderation by parental monitoring. Arch Gen Psychiatry2009; 66: 649-657.
156. Dick DM, Meyers JL, Latendresse SJ, Creemers HE, Lansford JE, Pettit GS et al. CHRM2, parental monitoring, and adolescent externalizing behavior: evidence for gene-environment interaction. Psychol Sci2011; 22: 481-489.
157. Nelson EC, Agrawal A, Pergadia ML, Wang JC, Whitfield JB, Saccone FS et al. H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated riskforalcohol consumption and dependence. Addict Biol2010; 15:1-11.
158. Nelson EC, Heath AC, Lynskey MT, Bucholz KK, Madden PA, Statham DJ et al. Childhood sexual abuse and risks for licit and illicit drug-related outcomes: a twin study. Psychol Med2006; 36:1473-1483. (Pubitemid 44355982)
159. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML et al. Epigenetic differencesarise duringthe lifetimeof monozygotictwins. Proc Natl Acad Sci USA2005; 102: 10604-10609.
160. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009; 301: 2462-2471.
161. Duncan LE, Keller MC A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry 2011; 168:1041-1049.
162. van Ijzendoorn MH, Bakermans-Kranenburg MJ, Belsky J, Beach S, Brody G, Dodge KA et al. Gene-by-environment experiments: a new approach to finding the missing heritability. Nat Rev Genet2011; 12:881.
163. Schnoll RA, Lerman C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opin Emerg Drugs 2006; 11: 429-444. (Pubitemid 44386368)
164. Hughes Jr. How confident should we be that smoking cessation treatments work? Addiction 2009; 104:1637-1640.
165. Sturgess JE, George TP, Kennedy JL, Heinz A, Muller DJ. Pharmacogenetics of alcohol, nicotine and drug addiction treatments. Addict Biol2011; 16: 357-376.
166. Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR et al. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 2003; 28:1546-1552. (Pubitemid 41070891)
167. Ray LA, Hutchison KE. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 2007; 64: 1069-1077. (Pubitemid 47360852)
168. Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H et al. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry2008; 65: 135-144. (Pubitemid 351222547)
169. Heilig M, Goldman D, Berrettini W, O'Brien CP. Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 2011; 12: 670-684.
170. Kenna GA. Medications acting on the serotonergic system for the treatment of alcohol dependent patients. Curr Pharm Des2010; 16: 2126-2135.
171. Mc Kay JD,Truong T, Gaborieau V, Chabrier A, Chuang SC, Byrnes G et al.Agenome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLo S Genet2011; 7: e1001333.
172. Brooks PJ, Enoch MA, Goldman D, Li TK, Yokoyama A. The alcohol flushing response: an unrecognized risk factor for esophageal cancerfrom alcohol consumption. PLo S Med 2009; 6: e50.
173. Brooks PJ, Goldman D, Li TK. Alleles of alcohol and acetaldehyde metabolism genes modulate susceptibility to oesophageal cancer from alcohol consumption. Hum Genomics 2009; 3:103-105.
174. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A et al. Common 5p15.33 and 6p21.33variants influence lung cancer risk. Nat Genet2008; 40:1407-1409.
175. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642. (Pubitemid 351483366)
176. Hung RJ, Mc Kay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452:633-637. (Pubitemid 351483367)
177. Saccone NL, Culverhouse RC, Schwantes-An TH, Cannon DS, Chen X, Cichon S et al. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLo S Genet2010; 6, pii: e1001053.
178. Wacholder S, Chatterjee N, Caporaso N. Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer. J Natl Cancer Inst 2008; 100:1488-1491.
179. Calandrella D, Antonini A. Pathological gambling in Parkinson's disease: disease related ordrug related? Expert Rev Neurother 2011; 11: 809-814.
180. Bell RL, Rodd ZA, Lumeng L, Murphy JM, Mc Bride WJ. The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol 2006; 11: 270-288. (Pubitemid 46696904)
181. Sommer W, Hyytia P, Kiianmaa K. The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking. Addict Biol2006; 11: 289-309. (Pubitemid 46696912)
182. Crabbe JC, Harris RA, Koob GF. Preclinical studies of alcohol binge drinking. Ann N Y Acad Sci2011; 1216: 24-40.
183. Heberlein U. Genetics of alcohol-induced behaviors in Drosophila. Alcohol Res Health 2000; 24: 185-188.
184. Crabbe JC. Consilience of rodent and human phenotypes relevant for alcohol dependence. Addict Biol2010; 15:103-108.
185. Merikangas KR, Risch N. Genomicpriorities and public health. Science2003; 302:599-601.
186. Hirschhorn JN. Genomewide association studies\-illuminating biologic pathways. N Engl JMed2009; 360:1699-1701.
187. Oze I, Matsuo K, Wakai K, Nagata C, Mizoue T, Tanaka K et al. Alcohol drinking and esophageal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2011; 41: 677-692.
188. Luo X, Kranzler HR, Zuo L, Wang S, Schork NJ, Gelernter J. Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. Am JHum Genet2006; 78: 973-987. (Pubitemid 43787689)
189. Macgregor S, Lind PA, Bucholz KK, Hansell NK, Madden PA, Richter MM et al. Asso-ciations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. Hum Mol Genet2009; 18: 580-593.
190. Li D, Zhao H, Gelernter J. Strong Association of the Alcohol Dehydrogenase 1B Gene (ADH1B) with alcohol dependence and alcohol-induced medical diseases. Biol Psychiatry 2011; 70: 504-512.
191. Soyka M, Preuss UW, Hesselbrock V, Zill P, Koller G, Bondy B. GABA-A2 receptor subunitgene(GABRA2)polymorphismsandriskforalcoholdependence. JPsychiatr Res 2008; 42: 184-191.
192. Noble EP, Blum K. Alcoholism and the D2 dopamine receptor gene. JAMA 1993; 270: 1547-1548.
193. Munafo MR, Matheson IJ, Flint J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 2007;12: 454-461. (Pubitemid 46652456)
194. Smith L, Watson M, Gates S, Ball D, Foxcroft D. Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a Hu GE gene-disease association review. Am J Epidemiol2008; 167:125-138.
195. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X et al. Variants in nicotinic receptors and riskfor nicotine dependence. Am JPsychiatry2008; 165:1163-1171.
196. Kuryatov A, Berrettini W, Lindstrom J. Acetylcholine receptor (ACh R) alpha5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (alpha4beta2)alpha5 ACh R function. Mol Pharmacol 2011; 79:119-125.
197. Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE. Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol2008; 75:178-195. (Pubitemid 350235400)
198. Heath AC Persist or quit? Testing for a genetic contribution to smoking persistence. Acta Genet Med Gemellol (Roma) 1990; 39: 447-458.
199. Hughes Jr. Should criteria for drug dependence differ across drugs? Addiction 2006; 101(Suppl1): 134-141. (Pubitemid 44199505)
200. Mc Bride O, Strong DR, Kahler CW. Exploring the role of a nicotine quantity-frequency use criterion in the classification of nicotine dependence and the stability of a nicotine dependence continuum overtime. Nicotine Tob Res2010; 12: 207-216.
201. Strong DR, Kahler CW, Colby SM, Griesler PC, Kandel D. Linking measures of adolescent nicotine dependence to a common latent continuum. Drug Alcohol Depend 2009; 99: 296-308.
202. Bierut LJ, Dinwiddie SH, Begleiter H, Crowe RR, Hesselbrock V, Nurnberger Jr JI et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry 1998; 55: 982-988. (Pubitemid 28506839)
203. Kaprio J, Hammar N, Koskenvuo M, Floderus-Myrhed B, Langinvainio H, Sarna S. Cigarette smoking and alcohol use in Finland and Sweden: a cross-national twin study. Int J Epidemiol1982;11: 378-386. (Pubitemid 13251690)
204. Pergadia ML, Heath AC, Martin NG, Madden PA. Genetic analysis of DSM-IV nicotine withdrawal in adulttwins. Psychol Med 2006; 36: 963-972. (Pubitemid 43827368)
205. Han S, Gelernter J, Luo X, Yang BZ. Meta-analysis of 15 genome-wide linkage scans of smoking behavior. Biol Psychiatry2010; 67:12-19.
206. Boardman JD.State-levelmoderationofgenetictendenciestosmoke.Am JPublic Health 2009; 99: 480-486.
207. Johnson EO, Chen LS, Breslau N, Hatsukami D, Robbins T, Saccone NL et al. Peer smoking and the nicotinic receptor genes: an examination of genetic and environmental risks for nicotine dependence. Addiction 2010; 105: 2014-2022.
208. Chen LS, Johnson EO, Breslau N, Hatsukami D, Saccone NL, Grucza RA et al. Interplay of genetic risk factors and parent monitoring in risk for nicotine dependence. Addiction 2009; 104: 1731-1740.
209. Weiss RB, Baker TB, Cannon DS, von NA, Dunn DM, Matsunami N et al. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLo S Genet2008; 4: e1000125.
210. Grucza RA, Johnson EO, Krueger RF, Breslau N, Saccone NL, Chen LS et al. Incorporating age at onset of smoking into genetic models for nicotine dependence: evidence for interaction with multiple genes. Addict Biol2010; 15: 346-357.
211. Vink JM, Smit AB, de Geus EJ, Sullivan P, Willemsen G, Hottenga JJ et al. Genome-wide association study of smoking initiation and current smoking. Am J Hum Genet 2009; 84: 367-379.
212. Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA et al. Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther2010; 334:137-146.
213. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011; 471: 597-601.
214. Hong LE, Hodgkinson CA, Yang Y, Sampath H, Ross TJ, Buchholz B et al. A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc Natl Acad Sci USA2010; 107: 13509-13514.
215. Swan GE, Javitz HS, Jack LM, Wessel J, Michel M, Hinds DA et al. Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J 2011 (in press).
216. Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Mol Med2010; 16: 247-253.